These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32795308)

  • 1. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition.
    Price BR; Sudduth TL; Weekman EM; Johnson S; Hawthorne D; Woolums A; Wilcock DM
    J Neuroinflammation; 2020 Aug; 17(1):238. PubMed ID: 32795308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
    Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
    Shi Q; Chang C; Saliba A; Bhat MA
    J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice.
    Fan Y; Ma Y; Huang W; Cheng X; Gao N; Li G; Tian S
    J Chem Neuroanat; 2019 Apr; 97():71-79. PubMed ID: 30790627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models.
    Fassler M; Rappaport MS; Cuño CB; George J
    J Neuroinflammation; 2021 Jan; 18(1):19. PubMed ID: 33422057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
    Wang Y; Ulland TK; Ulrich JD; Song W; Tzaferis JA; Hole JT; Yuan P; Mahan TE; Shi Y; Gilfillan S; Cella M; Grutzendler J; DeMattos RB; Cirrito JR; Holtzman DM; Colonna M
    J Exp Med; 2016 May; 213(5):667-75. PubMed ID: 27091843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
    Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
    Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer's Disease Mouse Model.
    Yuan Q; Liu X; Zhang Y; Xian YF; Zou J; Zhang X; Huang P; Song YQ; Lin ZX
    Molecules; 2021 May; 26(9):. PubMed ID: 34064330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
    Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a
    Parhizkar S; Gent G; Chen Y; Rensing N; Gratuze M; Strout G; Sviben S; Tycksen E; Zhang Q; Gilmore PE; Sprung R; Malone J; Chen W; Remolina Serrano J; Bao X; Lee C; Wang C; Landsness E; Fitzpatrick J; Wong M; Townsend R; Colonna M; Schmidt RE; Holtzman DM
    Sci Transl Med; 2023 Apr; 15(693):eade6285. PubMed ID: 37099634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
    Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
    Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
    FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Trem2
    Tran KM; Kawauchi S; Kramár EA; Rezaie N; Liang HY; Sakr JS; Gomez-Arboledas A; Arreola MA; Cunha CD; Phan J; Wang S; Collins S; Walker A; Shi KX; Neumann J; Filimban G; Shi Z; Milinkeviciute G; Javonillo DI; Tran K; Gantuz M; Forner S; Swarup V; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; MacGregor GR; Green KN
    Mol Neurodegener; 2023 Feb; 18(1):12. PubMed ID: 36803190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
    Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
    Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.